Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Francesco Annunziato and Federico Lavorini.
Francesco Annunziato
Connection Strength
0.171
Federico Lavorini
  1. Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab. PLoS Pathog. 2021 02; 17(2):e1009243.
    View in: PubMed
    Score: 0.058
  2. Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab. Immunol Lett. 2020 12; 228:122-128.
    View in: PubMed
    Score: 0.057
  3. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020 09 01; 130(9):4694-4703.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.